BSE filing, NSE: BETXIND. Summary written from the filing by ALFA Finder's alert engine.
Betex India Ltd: key numbers
- Share price
- ₹381.50
- Market cap
- ₹57.22 Cr
- Revenue (annual)
- ₹100.3 Cr
- Net profit (annual)
- ₹5.67 Cr
- P/E (TTM)
- 9.6×Sector 49.5×
- Promoter holding
- 53.29%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Betex India Ltd
All →Betex India Management Change
Betex India Limited has re-appointed Mr. Hanumansingh Karansingh Shekhawat as a Non-Executive Independent Director. The appointment is for a second term of five years effective February 10, 2027.
- Execution
- 60 months
Betex India Annual General Meeting
Betex India Limited held its 39th Annual General Meeting on September 30, 2026. Key businesses included financial statement adoption, director re-appointments, and related party transaction approvals.
Betex India Annual Report
Betex India Limited submitted its Annual Report for the financial year 2025-26 and notice for its 39th Annual General Meeting.
Betex India Other Announcement
Betex India Ltd has intimated book closure from 24 to 30 September 2026 for its 39th AGM. This is a routine Reg 42 SEBI LODR compliance filing.
Betex India Annual General Meeting
Betex India Ltd issued the notice for its 39th AGM on September 30, 2026. Agenda includes adoption of FY26 financials, director reappointments, and RPT approvals.
Betex India Board Meeting Outcome
Betex India Limited announced the re-appointment of an independent director, remuneration revision, and approved the notice and scheduling of its 39th Annual General Meeting.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.